节点文献

UCH-L1在弥漫大B细胞淋巴瘤中的表达及预后相关因素探讨

The expressions and prognostic impact of UCH-L1 in patients with diffuse large B-cell lymphoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王金洁徐如君

【Author】 Wang Jinjie;Xu rujun;Department of Pathology,affiliated Hangzhou First People’s Hospital,Zhejiang University School of Medicine;

【机构】 浙江大学医学院附属杭州市第一人民医院病理科

【摘要】 目的探讨弥漫大B细胞淋巴瘤中UCH-L1蛋白表达情况及其对临床病理特征和病人预后的影响。方法收集本院2014年至今存档石蜡包埋的DLBCL标本149例,按照Hans分型分为GCB和NonGCB两型,整理追踪病人的临床资料,6例反应性增生淋巴组织作为正常对照。免疫组织化学方法检测UCH-L1的表达并分析其与淋巴瘤分型和患者预后的关系,同时检测Bcl-2、Bcl-6和Ki-67等蛋白的表达情况。结果149例DLBCL患者中36例存在UCH-L1高表达,其中Non-GCB型16例(16/104,阳性率15%),GCB型20例(20/45,阳性率44%),两者差异具有统计学意义(P=0.000)。UCH-L1高表达与患者年龄(<60岁)有关,与性别无关(P值为0.018、0.552)。UCH-L1高表达的患者较低表达组具有更高的临床分期、LDH水平和IPI评分值(均P<0.05),而患者的白蛋白水平、有无B症状和骨髓累积在两组之间无明显差异。Bcl-2、Bcl-6和Ki-67的阳性表达率在UCH-L1高、低表达组间差异也无明显的统计学意义。结论UCH-L1高表达在GC源性DLBCL患者中更为普遍,其表达异常预示患者预后不良,它是一个良好的预后指标,对其表达进行抑制可能实现对DLBCL的有效基因治疗。

【Abstract】 Objective To investigate the expressions and prognostic impact of UCH-L1 in patients with diffuse large B-cell lymphoma(DLBCL) and its related factors.Methods One hundred and forty-nine paraffin specimens of DLBCL were collected from 2014 up to date,and classified into germinal center B-cell(GCB) type and NonGCB type according to Hans classification.Clinical information was collected and tracted.Six reactive hypertrophic lymphoid tissues were collected as a control.Immunohistochemical method was performed to detect the expression of UCH-L1 in these tissues.The correlation between UCH-L1 and the prognoses of these patients was analyzed.Also,the expression of Bcl-2,Bcl-6 and Ki-67 were detected.Results In all 149 DLBCL cases,UCH-L1 was overexpressed in 36 cases,including 16 cases in Non-GCB type(16/104,15%) and 20 cases in GCB type(20/45,44%),the difference was statistically significant(P=0.000).UCH-L1 expression was correlated with age of patients and not with gender.Higher clinical stage,LDH level and IPI score values were detected in UCH-L1 positive group compared with UCH-L1 negative group(P<0.05),while the albumin levels,B symptoms and bone marrow involvement were no obvious difference between two groups.The positive rates of Bcl-2,Bcl-6 and Ki-67 were also no difference between two groups.Comclusions Over-expression of UCH-L1 tended to appear in GCB type of DLBCL and was associated with poor outcome.It is a good prognostic indicator.Inhibition of UCH-L1 expression may achieve effective gene therapy for DLBCL..

【关键词】 UCH-L1弥漫大B细胞淋巴瘤预后
【Key words】 UCH-L1diffuse large B-cell lymphomaprognosis
  • 【会议录名称】 2019年浙江省病理技术学术大会暨第六届长三角病理技术学术会议论文汇编
  • 【会议名称】2019年浙江省病理技术学术大会暨第六届长三角病理技术学术会议
  • 【会议时间】2019-06-21
  • 【会议地点】中国浙江宁波
  • 【分类号】R733.1
  • 【主办单位】浙江省医学会
节点文献中: 

本文链接的文献网络图示:

本文的引文网络